151 related articles for article (PubMed ID: 34153801)
1. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
[No Abstract] [Full Text] [Related]
3. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
[TBL] [Abstract][Full Text] [Related]
4. [Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].
Kadowaki S; Matsuda N; Moriya A; Ebitani M; Yoshihara A; Nakamura K; Mochizuki H; Ugawa Y
Rinsho Shinkeigaku; 2011 Apr; 51(4):261-6. PubMed ID: 21595295
[TBL] [Abstract][Full Text] [Related]
5. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.
Yalcin Kehribar D; Gunaydin S; Ozgen M
Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044
[TBL] [Abstract][Full Text] [Related]
6. Neurological Sequelae in Youngest Adult Behcet's Disease Patient on Infliximab.
Sultan M; Khan A; Habib SS; Hayat M
J Coll Physicians Surg Pak; 2020 Jul; 30(7):762-764. PubMed ID: 32811612
[TBL] [Abstract][Full Text] [Related]
7. Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab.
Uygunoğlu U; Pasha M; Saip S; Siva A
J Spinal Cord Med; 2015 Jan; 38(1):111-4. PubMed ID: 24673549
[TBL] [Abstract][Full Text] [Related]
8. Effect of infliximab in progressive neuro-Behçet's syndrome.
Kikuchi H; Aramaki K; Hirohata S
J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines.
Hamzaoui K; Borhani-Haghighi A; Kaabachi W; Hamzaoui A
Cell Mol Immunol; 2014 Nov; 11(6):613-6. PubMed ID: 24909741
[No Abstract] [Full Text] [Related]
10. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
[No Abstract] [Full Text] [Related]
11. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
[TBL] [Abstract][Full Text] [Related]
12. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
Barešić M; Reihl M; Habek M; Vukojević N; Anić B
Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
[TBL] [Abstract][Full Text] [Related]
13. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
Desbois AC; Biard L; Addimanda O; Lambert M; Hachulla E; Launay D; Ackermann F; Pérard L; Hot A; Maurier F; Mausservey C; Bernard F; Noel N; Alric L; Mirault T; Cohen F; Boussouar S; Resche-Rigon M; Cacoub P; Saadoun D
Clin Immunol; 2018 Dec; 197():54-59. PubMed ID: 30125675
[TBL] [Abstract][Full Text] [Related]
15. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
Sfikakis PP; Theodossiadis PG; Katsiari CG; Kaklamanis P; Markomichelakis NN
Lancet; 2001 Jul; 358(9278):295-6. PubMed ID: 11498218
[TBL] [Abstract][Full Text] [Related]
16. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
17. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab.
Coulter I; Huda S; Baborie A; Jacob A
J Spinal Cord Med; 2012 Mar; 35(2):122-4. PubMed ID: 22333754
[TBL] [Abstract][Full Text] [Related]
18. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
[No Abstract] [Full Text] [Related]
19. Infliximab in refractory uveitis due to Behçet's disease.
Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of coronary artery aneurysm with infliximab in a Behçet's disease patient.
Satış H; Cindil E; Ataş N; Salman RB; Tufan A
Rheumatology (Oxford); 2021 Jan; 60(1):e10-e11. PubMed ID: 32780835
[No Abstract] [Full Text] [Related]
[Next] [New Search]